Low, Jenny G.H.

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 1,887

Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients

Tan, A. T., Linster, M., Tan, C. W., Le Bert, N., Chia, W. N., Kunasegaran, K., Zhuang, Y., Tham, C. Y. L., Chia, A., Smith, G. J. D., et al. (2021) · Cell Reports

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 740

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection

Le Bert, N., Clapham, H. E., Tan, A. T., Chia, W. N., Tham, C. Y. L., Lim, J. M., Kunasegaran, K., Tan, L. W. L., Dutertre, C.-A., Shankar, N., et al. (2021) · Journal of Experimental Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 330

A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice

de Alwis, R., Gan, E. S., Chen, S., Leong, Y. S., Tan, H. C., Zhang, S. L., Yau, C., Low, J. G. H., Kalimuddin, S., Matsuda, D., et al. (2021) · Molecular Therapy

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 191

A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine

Low, J. G., de Alwis, R., Chen, S., Kalimuddin, S., Leong, Y. S., Mah, T. K. L., Yuen, N., Tan, H. C., Zhang, S. L., Sim, J. X. Y., et al. (2022) · npj Vaccines

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 61

A phase 1/2 randomized, double-blinded, placebo controlled ascending dose trial to assess the safety, tolerability and immunogenicity of ARCT-021 in healthy adults

Low, J. G., de Alwis, R., Chen, S., Kalimuddin, S., Leong, Y. S., Mah, T. K. L., Yuen, N., Tan, H. C., Zhang, S. L., Sim, J. X. Y., et al. (2021) · medRxiv

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 19

Secreted dengue virus NS1 from infection is predominantly dimeric and in complex with high-density lipoprotein

Chew, B. L. A., Ngoh, A. Q., Phoo, W. W., Chan, K. W. K., Ser, Z., Tulsian, N. K., Lim, S. S., Weng, M. J. G., Watanabe, S., Choy, M. M., et al. (2024) · eLife

Mosquito-borne diseases and controlEnzyme Structure and Function

Cited by 1

Secreted dengue virus NS1 from infection is predominantly dimeric and in complex with high-density lipoprotein

Chew, B. L. A., Ngoh, A. Q., Phoo, W. W., Chan, K. W. K., Ser, Z., Tulsian, N. K., Lim, S. S., Weng, M. J. G., Watanabe, S., Choy, M. M., et al. (2024) · eLife

Mosquito-borne diseases and controlEnzyme Structure and Function

Cited by 0